ao link
Who's Who Legal
Who's Who Legal
Menu
Thought Leaders

Thought Leaders

Thought Leader

Global Leader

Healthcare 2021

Professional Biography

WWL Ranking: Recommended

WWL says

Andri Hess is singled out by “impressed” sources thanks to his “top-class” IP advice to major clients in the pharmaceutical sector.

Biography

Andri Hess is a partner and a member of Homburger’s IP/IT, litigation and arbitration, and competition and regulatory practice teams. He has extensive experience in representing clients in patent and other intellectual property rights related litigation and arbitration in a broad range of technical and industrial fields and within international contexts, as well as in negotiating and drafting intellectual property rights related contracts. Andri Hess also represents clients in regulatory matters before the Swiss Agency for Therapeutic Products and the Federal Office of Public Health.

Andri Hess is a board member of the Swiss group of AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle) and a member of the Programme Committee of AIPPI International. Moreover, he is member of ASA (Swiss Arbitration Association), GRUR, INGRES (Institut für gewerblichen Rechtsschutz) as well as of the Zurich and Swiss Bar Associations.

Andri Hess is editor of the journal Life Science Recht – The Law Journal for Pharma, Biotech and Medtech, as well as of the only commentary of the Swiss Federal Act on the Federal Patent Court. Aside of this, he commented several provisions of the Swiss Patent Act in the most recent and comprehensive commentary, published numerous articles in various intellectual property and especially in patent rights related topics, regularly holds presentations before Swiss and international professional associations, and he teaches at the University of Stockholm and at the Federal Institute of Intellectual Property.

Andri Hess is elected associate judge at the Swiss Federal Patent Court. He is fluent in German and English.

WWL Ranking: Recommended
WWL Ranking: Recommended

WWL says

Andri Hess secures impressive endorsements from peers for his transactional work in the life sciences space, as well as related regulation.

Biography

Andri Hess is a partner and a member of Homburger’s IP/IT, litigation and arbitration, and competition and regulatory practice teams. He has extensive experience in representing clients in patent and other intellectual property rights related litigation and arbitration in a broad range of technical and industrial fields and within international contexts, as well as in negotiating and drafting intellectual property rights related contracts. Andri Hess also represents clients in regulatory matters before the Swiss Agency for Therapeutic Products and the Federal Office of Public Health.

Andri Hess is a board member of the Swiss group of AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle) and a member of the Programme Committee of AIPPI International. Moreover, he is member of ASA (Swiss Arbitration Association), GRUR, INGRES (Institut für gewerblichen Rechtsschutz) as well as of the Zurich and Swiss Bar Associations.

Andri Hess is editor of the journal Life Science Recht – The Law Journal for Pharma, Biotech and Medtech, as well as of the only commentary of the Swiss Federal Act on the Federal Patent Court. Aside of this, he commented several provisions of the Swiss Patent Act in the most recent and comprehensive commentary, published numerous articles in various intellectual property and especially in patent rights related topics, regularly holds presentations before Swiss and international professional associations, and he teaches at the University of Stockholm and at the Federal Institute of Intellectual Property.

Andri Hess is elected associate judge at the Swiss Federal Patent Court. He is fluent in German and English.
WWL Ranking: Recommended

WWL says

Andri Hess is described by market commentators as "one of the best patent lawyers in Switzerland". He is renowned for his excellence in the litigation and arbitration of patent disputes in the life sciences sector. 

Biography

Andri Hess is a partner and a member of Homburger’s IP/IT, litigation and arbitration, and competition and regulatory practice teams. He has extensive experience in representing clients in patent and other intellectual property rights related litigation and arbitration in a broad range of technical and industrial fields and within international contexts, as well as in negotiating and drafting intellectual property rights related contracts. Andri Hess also represents clients in regulatory matters before the Swiss Agency for Therapeutic Products and the Federal Office of Public Health.

Andri Hess is a board member of the Swiss group of AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle) and a member of the Programme Committee of AIPPI International. Moreover, he is member of ASA (Swiss Arbitration Association), GRUR, INGRES (Institut für gewerblichen Rechtsschutz) as well as of the Zurich and Swiss Bar Associations.

Andri Hess is editor of the journal Life Science Recht – The Law Journal for Pharma, Biotech and Medtech, as well as of the only commentary of the Swiss Federal Act on the Federal Patent Court. Aside of this, he commented several provisions of the Swiss Patent Act in the most recent and comprehensive commentary, published numerous articles in various intellectual property and especially in patent rights related topics, regularly holds presentations before Swiss and international professional associations, and he teaches at the University of Stockholm and at the Federal Institute of Intellectual Property.

Andri Hess is elected associate judge at the Swiss Federal Patent Court. He is fluent in German and English.

National Leader

WWL Ranking: Recommended
WWL Ranking: Recommended
Law Business Research
Law Business Research Ltd
Meridian House, 34-35 Farringdon Street
London EC4A 4HL, UK
© Law Business Research Ltd 1998-2021. All rights reserved.
Company No.: 03281866